Article
Effects of the dopamine D3 receptor (DRD3) gene polymorphisms on risperidone response: a pharmacogenetic study.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology - 1 Jan 2008
Xuan Jiekun, Zhao Xinzhi, He Guang, Yu Lan, Wang Lei, Tang Wei, Li Xingwang, Gu Niufan, Feng Guoyin, Xing Qinghe, He Lin
Abstract excerpt
Previous observations of the anatomical distribution and pharmacological profile of the dopamine D(3) receptor (DRD3) have indicated its potential role in antipsychotic drug action. Risperidone, an effective first-line atypical antipsychotic agent, exhibits a relatively high affinity for this receptor. Recent studies have reported an association of the Ser9Gly polymorphism in the DRD3 gene with therapeutic...
Topics
- Adult
- Age of Onset
- Antipsychotic Agents
- DNA
- Humans
- Polymerase Chain Reaction
- Polymorphism, Genetic
- Polymorphism, Single Nucleotide
- Receptors, Dopamine D3
- Risperidone
